10 results
PRE 14A
THRX
Theseus Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
9:00am
executive retention because they incentivize our executive officers, including our named executive officers, to remain in our employment during
DEF 14A
THRX
Theseus Pharmaceuticals Inc
25 Apr 22
Definitive proxy
4:30pm
the interests of our executives and our stockholders. In addition, we believe that equity grants promote executive retention because they incentivize our
424B4
THRX
Theseus Pharmaceuticals Inc
7 Oct 21
Prospectus supplement with pricing info
5:03pm
grants promote executive retention because they incentivize our executive officers, including our named executive officers, to remain in our employment
S-1/A
THRX
Theseus Pharmaceuticals Inc
30 Sep 21
IPO registration (amended)
6:33am
that equity grants promote executive retention because they incentivize our executive officers, including our named executive officers, to remain in our
S-1
EX-10.2
is5m34q
15 Sep 21
IPO registration
4:04pm
S-1
u2nkgt yq
15 Sep 21
IPO registration
4:04pm
DRS/A
t9c9ay5 l18o6d60ejp
23 Aug 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.2
0d4uv
23 Aug 21
Draft registration statement (amended)
12:00am
DRS
gfz2r40yvq
20 Jul 21
Draft registration statement
12:00am
- Prev
- 1
- Next